Marsh & McLennan, US5717481023

Marsh & McLennan stock holds steady after 2025 earnings growth

Published on 07/20/2026 at 08:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Marsh & McLennan stock reflects 2025 revenue of $24.8 billion and adjusted EPS of $8.03, with the latest annual report dated 31 December 2025.

Pop-Art-Comic zeigt Handschlag zwischen Berater und Kunde mit Sprechblase DEAL
Marsh & McLennan (ISIN US5717481023) als farbenfrohe Pop-Art-Comic-Szene eines Versicherungsberaters beim Vertragsabschluss, Illustration mit AI erstellt.

Marsh & McLennan (US5717481023) reported 2025 revenue of $24.8 billion and adjusted earnings per share of $8.03, two figures that frame the stock's latest fundamental backdrop. The company also returned $3.6 billion to shareholders through dividends and buybacks in 2025.

2025 revenue reached $24.8 billion

Revenue for 2025 increased to $24.8 billion, while adjusted operating income rose to $5.0 billion and adjusted operating margin reached 20.2% in the same period. Net income attributable to the company was $4.6 billion in 2025, up from $4.2 billion a year earlier.

The annual report for 2025 shows adjusted EPS of $8.03, compared with $7.13 in 2024. That 12.6% increase gives investors a clear year-over-year comparison for earnings quality and capital return capacity.

Margin above 20%

Adjusted operating margin held above 20% in 2025, a level that helps distinguish the business from lower-margin insurance and consulting peers. Free cash flow was $4.2 billion in 2025, while capital expenditures remained modest at $232 million.

Debt also stayed manageable in 2025, with total debt at $16.2 billion and cash and cash equivalents at $2.1 billion. The balance sheet matters because the group combines advisory fees, risk management, and insurance brokerage income, each of which tends to respond differently to market cycles.

Read deeper

Marsh & McLennan annual report highlights

The latest annual report gives the cleanest view of revenue, margin, earnings, and capital returns for 2025.

Brokerage and consulting mix

Marsh reported revenue of $17.2 billion in 2025, while Guy Carpenter generated $2.6 billion and Mercer produced $5.0 billion in the same year. Those segment figures show how the group spreads earnings across risk, reinsurance, health, retirement, and workforce consulting.

For investors, the spread matters because it reduces dependence on a single line of business. The 2025 figures also show that the two largest segments, Marsh and Mercer, together accounted for $22.2 billion of revenue.

Marsh and Mercer power results

Marsh remains the largest division, with 2025 revenue of $17.2 billion, and Mercer follows with $5.0 billion. Guy Carpenter added $2.6 billion, giving the group a broad revenue base across insurance brokerage and advisory services.

The company generated $4.2 billion in free cash flow in 2025, a level that supports dividends, repurchases, and reinvestment. Annual operating discipline is visible in the 20.2% adjusted operating margin and the $8.03 adjusted EPS figure reported for the year.

Closing valuation frame

Shares are not quoted here with a live market price, so the most useful current frame is the 2025 reporting base: $24.8 billion in revenue, $8.03 adjusted EPS, and $4.2 billion in free cash flow. That combination gives Marsh & McLennan stock a valuation backdrop centered on earnings resilience rather than a single trading-day catalyst.

Marsh & McLennan stock at a glance

  • Company: Marsh & McLennan Companies, Inc.
  • ISIN: US5717481023
  • Ticker: NYSE: MMC
  • Trading venue: NYSE
  • Sector / Industry: Financials / Insurance Brokers
  • Index membership: S&P 500
  • Next earnings date: 24 July 2026

Follow Marsh & McLennan discussions

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US5717481023 | MARSH & MCLENNAN | boerse | 69810261 | bgmi